Teladoc Health, Inc. (TDOC) Form 10-Q — Oct 29, 2026
Teladoc Health reported Q3 2026 revenue of $605.1 million, down 3% year over year, with net loss narrowing 46% to $26.9 million ($0.15 per share) and Adjusted EBITDA up 14% to $79.4 million. The drag came from BetterHelp, where revenue fell 13% to $206.6 million as cash-pay user demand shifted to insurance-covered services faster than provider capacity could absorb. In May 2026 the decline in cash-paying users accelerated beyond assumptions, and in July 2026 the company materially reduced its 2026 BetterHelp revenue expectations. Integrated Care grew 2% to $398.5 million in the quarter with a 13% Adjusted EBITDA improvement, but U.S.
Key figures
- Revenue
- 605102000
- Total Debt
- 1000000000
- Revenue Yoy
- -3%
- Total Assets
- 2775075000
- Cash Position
- 849909000
- Shares Outstanding
- 182293675
- Revolver available
- $297.2M of $300M undrawn
- Adjusted ebitda yoy
- +14%
- Betterhelp revenue q3
- 206641000
- Betterhelp revenue yoy
- -13%
- Convertible notes 2027
- $1.0B at 1.25% due June 1, 2027 (now current liability)
- Adjusted ebitda q3 2026
- 79358000
- Betterhelp paying users q3
- 0.336M (-12% YoY)
- Integrated care revenue q3
- 398461000
- Us integrated care members
- 100.1M (-2.4M, -2% YoY)
- Integrated care revenue yoy
- +2%
- Operating cash flow nine months
- 180636000
- Restructuring costs 2026 guidance
- $20.0M pre-tax for FY2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.